The European Council on Monday voted to move the European Medicines Agency’s (EMA) headquarters and nearly 900 staffers from London to Amsterdam – a move decided in a runoff. The transition is ...
The General Affairs Council of the European Union has decided that the European Medicines Agency (EMA) will relocate to Amsterdam when it leaves London in 2019. The EMA relocation is a direct ...
Following a vote by member states in favor of Amsterdam as the agency’s new headquarters, the relocation will take place over the next 16 months, with operations expected to start up in March 2019.
Following its Brexit-related departure from London, the European Medicines Agency’s (EMA) staff has been reduced from 897 staffers to 775, EMA said Friday in an update from a board meeting in its new ...
DUBLIN – With its future headquarters in Amsterdam not due to be ready until November 2019, the EMA unveiled the temporary building it will start to transition to from Jan. 1, 2019, during a press ...
Italian opposition to the move of the headquarters of the European Medicines Agency to Amsterdam appears to have been ended by the European parliament, the Financieele Dagblad said on Monday. The ...
European Union member states voted on Monday for the new location of the European Medicines Agency. With all eyes fixed on Monday's vote for the European Medicines Agency relocation, Amsterdam emerged ...
After months of lobbying from dozens of nations to bring the EMA to their cities, the EU has chosen Amsterdam as its new location. In what turned out to be a ‘penalty shootout’ of a voting process, ...
Amsterdam was chosen as the new home of the European Medicines Agency (EMA) yesterday in a high-drama selection process, which saw the decision come down to the toss of a coin. While there was bitter ...
The European Medicines Agency (EMA) will move into temporary accommodations half the size of its current home when it leaves London in 2019. That precipitous drop in the amount of space available to ...
Amsterdam was chosen as the new home of the European Medicines Agency (EMA) yesterday in a high-drama selection process, which saw the decision come down to the toss of a coin. While there was bitter ...